Review-State-Aware Comparison
African Nutmeg vs Amazonian Guaraná
An automated side-by-side view of two public profiles. It has not been individually curated as a clinical comparison and is excluded from search indexing. Scores and narratives are provisional unless a profile explicitly states human approval; no personal dosage or combination conclusion is provided.
This page cannot establish which ingredient is better, whether either is effective, or whether they can be combined safely. Editorial and quality-gate review approved this evidence record. Editorial and quality-gate review approved this evidence record.
African Nutmeg
Human-reviewed public score: 10/10
Amazonian Guaraná
Human-reviewed public score: 10/10Human-Reviewed Benefit Text
African Nutmeg
Amazonian Guaraná
Human-Reviewed Mechanism Text
African nutmeg's primary bioactive compounds—myristicin, eugenol, elemicin, and α-phellandrene—exert anti-inflammatory effects by inhibiting NF-κB nuclear translocation and suppressing COX-2 and iNOS enzyme expression, thereby reducing prostaglandin E2 and nitric oxide production. Eugenol and dehydrodiisoeugenol modulate the PI3K/Akt/mTOR and MAPK (ERK1/2, p38, JNK) signaling cascades, attenuating pro-inflammatory cytokine release (TNF-α, IL-1β, IL-6) while promoting cellular survival and antioxidant defense via Nrf2/ARE pathway activation. The enzyme inhibitory activity documented by Tamfu et al. (2020) includes acetylcholinesterase inhibition, which preserves acetylcholine levels at synaptic junctions and underlies the seed's cognitive-enhancing potential (PMID 33260317). Additionally, the terpenoid and phenolic fractions scavenge DPPH, ABTS, and hydroxyl radicals, chelate transition metals, and inhibit lipid peroxidation, providing multilayered oxidative stress protection (PMID 36400870).
Guaraná's primary bioactive methylxanthines—caffeine (2–5% dry weight), theobromine, and theophylline—competitively antagonize adenosine A1 and A2A receptors in the central nervous system, thereby blocking adenosine's inhibitory signaling, increasing synaptic dopamine and norepinephrine release, and enhancing alertness, reaction time, and sustained attention. Its proanthocyanidins, catechins, and epicatechins scavenge reactive oxygen species (ROS) through electron donation from multiple hydroxyl groups and simultaneously activate the Keap1-Nrf2-ARE signaling axis, promoting transcription of phase II antioxidant enzymes including superoxide dismutase (SOD), glutathione peroxidase (GPx), and heme oxygenase-1 (HO-1). Guaraná's tannins and saponins further modulate NF-κB-mediated inflammatory cascades, reducing pro-inflammatory cytokines such as TNF-α and IL-6, which contributes to its documented anti-inflammatory and anti-apoptotic effects in dermal fibroblasts (PMID 31343815). Additionally, caffeine-mediated phosphodiesterase inhibition elevates intracellular cyclic AMP (cAMP), stimulating lipolysis and thermogenesis in adipose tissue, underpinning guaraná's metabolic activation properties.
Human-Reviewed Safety Text
African nutmeg is generally recognized as safe when consumed in culinary amounts, consistent with its longstanding use in West and Central African cuisines and traditional medicine systems (PMID 22306470, PMID 24995835). However, myristicin in high doses may exhibit psychoactive effects and hepatotoxicity, so excessive intake beyond food-level quantities should be avoided, particularly in pregnant or nursing women. Due to eugenol's documented inhibition of CYP1A2 and CYP3A4 enzymes, concurrent use with anticoagulants (e.g., warfarin), antiplatelet drugs, or medications metabolized by these CYP450 isoforms warrants caution and physician consultation. Individuals on cholesterol-lowering medications (statins) should be aware of additive lipid-lowering effects, as M. myristica has demonstrated significant cholesterol reduction in animal models (PMID 26199582).
A comprehensive safety review by Patrick et al. (2019, PMID 31539257) confirmed that guaraná seed is generally recognized as safe (GRAS) when consumed at standard dietary doses (typically 75–200 mg/day caffeine equivalent), with adverse effects primarily dose-dependent and consistent with excess caffeine intake—including insomnia, tachycardia, anxiety, and gastrointestinal distress. Guaraná's caffeine is a substrate and inhibitor of cytochrome P450 1A2 (CYP1A2), and concurrent use with CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin) or substrates (e.g., theophylline, clozapine) may increase plasma caffeine levels and potentiate adverse effects. Guaraná should be used cautiously alongside anticoagulants (warfarin), MAO inhibitors, stimulant medications, and ephedra-containing products due to additive cardiovascular stimulation; it is contraindicated in individuals with uncontrolled hypertension, cardiac arrhythmias, or caffeine hypersensitivity. Pregnant and lactating women are advised to limit guaraná consumption consistent with general caffeine guidelines (≤200 mg caffeine/day per WHO recommendations).
Comparison summary
This automated view does not establish that either African Nutmeg or Amazonian Guaraná is effective, superior, suitable, or safe to combine. Both have the same provisional public score (10/10). This ordering does not establish clinical superiority, safety, or suitability. Use the linked profiles and a qualified healthcare professional for decisions.
Frequently Asked Questions
Is African Nutmeg or Amazonian Guaraná better?
African Nutmeg and Amazonian Guaraná have the same provisional public score (10/10). A score tie does not establish equivalent evidence or outcomes.
Can you take African Nutmeg and Amazonian Guaraná together?
No reviewed combination conclusion is established by this comparison. A missing reviewed interaction record means unknown, not safe. Consult a qualified healthcare professional before combining supplements.
What is the main difference between African Nutmeg and Amazonian Guaraná?
African Nutmeg is categorized as seed (Compound), while Amazonian Guaraná is categorized as seed (Compound). Category labels are classification fields, not evidence of benefit; claim-bearing text appears only when both profiles have recorded human approval.
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.